Clinical Genomics Pathology
Latest round
- Series B
Last raised
- Jun 2018
Total raised
- $41M
Investors
- 2
About Clinical Genomics Pathology
Clinical Genomics Pathology, Inc., founded in 2006 in Bridgewater, US, provides genomic testing solutions. The company has not undergone significant pivots or changes. The founders, Katrina Anderson and Tim Schottler, have a history in the healthcare sector.The company offers a suite of innovative genomic products and services designed to address specific needs within the healthcare industry. Their core product line includes advanced testing solutions that enhance diagnostic accuracy and provide data analytics capabilities. These offerings are primarily targeted at healthcare providers, contributing to improved patient care and operational efficiency.The company's revenue model is structured around a combination of subscription-based and direct sales approaches in the healthcare sector. Clients typically engage in annual subscription agreements for access to genomic testing services, with pricing plans based on volume and service complexity. These structured transactions facilitate predictable revenue streams, allowing the company to maintain strong customer relationships through ongoing support and updates.Clinical Genomics Pathology, Inc. plans to expand its product offerings with new genomic testing solutions scheduled for launch in the upcoming quarters, enhancing their existing portfolio. The company aims to enter new markets, particularly in Asia and South America, by the end of 2023.
Who invested in Clinical Genomics Pathology
2 investors across 2 rounds
See all investors in Clinical Genomics Pathology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Clinical Genomics Pathology
Who invested in Clinical Genomics Pathology?
Clinical Genomics Pathology has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Clinical Genomics Pathology raised?
Clinical Genomics Pathology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Clinical Genomics Pathology last raise money?
Clinical Genomics Pathology's most recent round on record is a Series B, in Jun 2018.
What does Clinical Genomics Pathology do?
Clinical Genomics Pathology, Inc.
Where is Clinical Genomics Pathology headquartered?
Clinical Genomics Pathology is headquartered in Bridgewater, US.
Which VCs invest in companies like Clinical Genomics Pathology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Clinical Genomics Pathology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Clinical Genomics Pathology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.